加州大型医疗系统SARS-CoV-2变异株分布(2021年3–7月)
研究利用Kaiser Permanente南加州大型集成医疗系统的SARS-CoV-2阳性标本全基因组测序数据,描述2021年3月4日至7月21日变异株分布及住院风险。13,039份阳性标本中6,798份(52%)完成测序,Alpha占比在3月4日至5月19日由20%升至67%,Delta占比在4月15日至7月21日由0%升至95%。Delta在18–44岁人群占比最高(55%),在已接种疫苗者中相对其他变异株更常见。
要点
- Alpha变异株周占比在2021年3–5月由20%升至67%。
- Delta变异株周占比在2021年4–7月由0%升至95%。
- Delta在18–44岁人群占比最高(55%)。
核心结论
- 2021年3–7月KPSC系统内Alpha和Delta变异株占比快速上升,Delta成为优势株。
研究设计与样本
- 利用KPSC大型集成医疗系统2021年3月4日至7月21日SARS-CoV-2阳性标本全基因组测序数据的观察性研究。
- 13,039份阳性标本中6,798份(52%)完成测序并纳入分析。
- 测序标本中5,994份(88%)来自未接种者,648份(10%)来自完全接种者,156份(2%)来自部分接种者。
主要发现
- Alpha变异株周占比在2021年3月4日至5月19日由20%升至67%。
- Delta变异株周占比在2021年4月15日至7月21日由0%升至95%。
- 完全接种与未接种者间变异株周占比相似,但Delta整体在接种者中相对其他变异株更常见。
- Delta在18–44岁人群占比最高(55%),并在非西班牙裔黑人中相对其他变异株更常见。
临床怎么用
- 应持续监测SARS-CoV-2变异株分布。
- 应实施多种COVID-19预防策略,尤其在Delta为优势株期间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data from observational studies demonstrate that variants of SARS-CoV-2, the virus that causes COVID-19, have evolved rapidly across many countries (1,2). The SARS-CoV-2 B.1.617.2 (Delta) variant of concern is more transmissible than previously identified variants,* and as of September 2021, is the predominant variant in the United States.† Studies characterizing the distribution and severity of illness caused by SARS-CoV-2 variants, particularly the Delta variant, are limited in the United States (3), and are subject to limitations related to study setting, specimen collection, study population, or study period (4-7). This study used whole genome sequencing (WGS) data on SARS-CoV-2-positive specimens collected across Kaiser Permanente Southern California (KPSC), a large integrated health care system, to describe the distribution and risk of hospitalization associated with SARS-CoV-2 variants during March 4-July 21, 2021, by patient vaccination status. Among 13,039 SARS-CoV-2-positive specimens identified from KPSC patients during this period, 6,798 (52%) were sequenced and included in this report. Of these, 5,994 (88%) were collected from unvaccinated persons, 648 (10%) from fully vaccinated persons, and 156 (2%) from partially vaccinated persons. Among all sequenced specimens, the weekly percentage of B.1.1.7 (Alpha) variant infections increased from 20% to 67% during March 4-May 19, 2021. During April 15-July 21, 2021, the weekly percentage of Delta variant infections increased from 0% to 95%. During March 4-July 21, 2021, the weekly percentage of variants was similar among fully vaccinated and unvaccinated persons, but the Delta variant was more commonly identified among vaccinated persons then unvaccinated persons overall, relative to other variants. The Delta variant was more prevalent among younger persons, with the highest percentage (55%) identified among persons aged 18-44 years. Infections attributed to the Delta variant were also more commonly identified among non-Hispanic Black persons, relative to other variants. These findings reinforce the importance of continued monitoring of SARS-CoV-2 variants and implementing multiple COVID-19 prevention strategies, particularly during the current period in which Delta is the predominant variant circulating in the United States.
引用
- Malden DE, Bruxvoort KJ, Tseng HF, et al. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34618801. doi:10.15585/mmwr.mm7040a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。